Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.970
-0.100 (-4.83%)
At close: May 19, 2026, 4:00 PM EDT
2.098
+0.128 (6.49%)
After-hours: May 19, 2026, 7:59 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $193.57 million as of May 19, 2026. Its market cap has increased by 136.51% in one year.
Market Cap
193.57M
Enterprise Value
111.71M
1-Year Change
136.51%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $193.57M, a decrease of -78.21%. That is a compound annual growth rate of -27.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 203.40M | 36.86% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 212.24M |
| MediWound | 210.58M |
| Whitehawk Therapeutics | 210.07M |
| Cartesian Therapeutics | 202.44M |
| Fate Therapeutics | 201.65M |
| Keros Therapeutics | 201.09M |
| Arcturus Therapeutics Holdings | 199.81M |
| Humacyte | 199.46M |